ES2068502T3 - Un preparado farmaceutico de nitroglicerina, del tipo de administracion percutanea. - Google Patents

Un preparado farmaceutico de nitroglicerina, del tipo de administracion percutanea.

Info

Publication number
ES2068502T3
ES2068502T3 ES91303066T ES91303066T ES2068502T3 ES 2068502 T3 ES2068502 T3 ES 2068502T3 ES 91303066 T ES91303066 T ES 91303066T ES 91303066 T ES91303066 T ES 91303066T ES 2068502 T3 ES2068502 T3 ES 2068502T3
Authority
ES
Spain
Prior art keywords
preparation
weight
nitroglycerine
concentration
acrylates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91303066T
Other languages
English (en)
Inventor
Takashi Nakagawa
Hiroko Tsukahara
Masayasu Kurono
Makoto Sato
Tsutomu Ishida
Kazushi Tokita
Mitsuji Nakano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Sanwa Kagaku Kenkyusho Co Ltd
Sekisui Chemical Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Sekisui Chemical Co Ltd
Nippon Oil and Fats Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd, Sekisui Chemical Co Ltd, Nippon Oil and Fats Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Application granted granted Critical
Publication of ES2068502T3 publication Critical patent/ES2068502T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE SUMINISTRA UNA PREPARACION FARMACEUTICA DE NITROGLICERINA DE TIPO DE ADMINISTRACION SUBCUTANEA. LA PREPARACION COMPRENDE UN SOPORTE PREVIO A LAS MEDICINAS, Y UNA CAPA ADHESIVA SENSITIVA A LA PRESION QUE ESTA SITUADA EN UNA SUPERFICIE DE DICHO SOPORTE, DONDE DICHA CAPA ADHESIVA SENSIBLE A LA PRESION CONTIENE UN (CO)POLIMERO ALQUILO (MET)ACRILATO EN UNA CONCENTRACION DE 1 35-85% POR PESO, NITROGLICERINA EN UNA CONCENTRACION DEL 10-30% POR PESO, Y UN ANHIDRIDO DE ACIDO SILICICO EN UNA CONCENTRACION DEL 5-20% POR PESO, DICHO (CO)POLIMERO CONTIENE COMO MAYOR COMPONENTE (CO)POLIMERO (MET)ACRILATOS ALQUILOS CON GRUPOS ALQUILOS TENIENDO 6 O MAS ATOMOS DE CARBONO, CUYOS (MET)ACRILATOS ALQUILOS INCLUYEN METACRILATO ETILEXILO-2 EN UNA CONCENTRACION DEL 40-100% POR PESO BASADO EN EL PESO TOTAL DE DICHOS (MET)ACRILATOS ALQUILOS. LA PREPARACION HACE POSIBLE A LA NITROGLICERINA EL SER ABSORBIDA SUBCUTANEAMENTE EN UNA PROPORCION CONTROLADA DURANTE UN LARGO PERIODO DE TIEMPO. TAMBIEN HASTA UNA PREPARACION COMPACTA PUEDE SUMINISTRAR UNA CANTIDAD SUFICIENTE DE NITROGLICERINA. SIN EMBARGO, LA PREPARACION PUEDE SER FABRICADA CON UN COSTE BAJO SIN NINGUN PROCESO COMPLICADO.
ES91303066T 1990-04-06 1991-04-08 Un preparado farmaceutico de nitroglicerina, del tipo de administracion percutanea. Expired - Lifetime ES2068502T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2092694A JPH07116032B2 (ja) 1990-04-06 1990-04-06 ニトログリセリン貼付剤

Publications (1)

Publication Number Publication Date
ES2068502T3 true ES2068502T3 (es) 1995-04-16

Family

ID=14061609

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91303066T Expired - Lifetime ES2068502T3 (es) 1990-04-06 1991-04-08 Un preparado farmaceutico de nitroglicerina, del tipo de administracion percutanea.

Country Status (11)

Country Link
US (1) US5260064A (es)
EP (1) EP0450986B1 (es)
JP (1) JPH07116032B2 (es)
KR (1) KR0163597B1 (es)
CA (1) CA2039869C (es)
DE (1) DE69107493T2 (es)
DK (1) DK0450986T3 (es)
ES (1) ES2068502T3 (es)
FI (1) FI102038B1 (es)
IE (1) IE66144B1 (es)
NO (1) NO177663C (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
WO1992022292A1 (de) * 1991-06-10 1992-12-23 Schwarz Pharma Ag Nitroglycerin-pflaster und verfahren zu seiner herstellung
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
GB2273044B (en) * 1992-12-02 1997-04-09 Pacific Chem Co Ltd Medicinal patches for percutaneous administration
JP2539330B2 (ja) * 1993-05-11 1996-10-02 日東電工株式会社 医療用粘着剤及びこれを用いて形成された医療用外用材
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2166869A1 (en) * 1993-07-09 1995-01-19 Ooi Wong Method and device for providing nicotine replacement therapy transdermally/transbuccally
AU7566994A (en) * 1993-08-16 1995-03-14 Cygnus Therapeutic Systems Contact adhesive extends wear time on skin
JPH0827003A (ja) * 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
WO1996022084A2 (en) * 1995-01-19 1996-07-25 Cygnus, Inc. Polymer adhesive formulation containing sorbent particles
DE19830648A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Glyceroltrinitrathaltige Zusammensetzung, Verfahren zu ihrer Herstellung und ihre Verwendung
JP2002064276A (ja) * 2000-08-22 2002-02-28 Nippon Steel Chem Co Ltd 光又は熱硬化性樹脂組成物及び多層プリント配線基板
JP2003335703A (ja) * 2002-05-16 2003-11-28 Eisai Co Ltd 肥厚性幽門狭窄症の治療薬及び同治療用キット
WO2008032718A1 (en) * 2006-09-11 2008-03-20 Sekisui Chemical Co., Ltd. Adhesive preparation
US20090317452A1 (en) * 2006-09-11 2009-12-24 Sekisui Chemical Co. Td. Transdermal patch
US9914848B1 (en) * 2016-10-31 2018-03-13 Ppg Architectural Finishes, Inc. Refinish coating composition
WO2019065392A1 (ja) * 2017-09-29 2019-04-04 キヤノン株式会社 シリカ凝集体、吸着材、吸着カラム、浄化システム、液体の処理方法、およびシリカ凝集体の製造方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5916576B2 (ja) * 1977-07-08 1984-04-16 旭化成株式会社 難燃性ポリフエニレンエ−テル組成物
JPS552604A (en) * 1978-06-20 1980-01-10 Sanwa Kagaku Kenkyusho:Kk Patch agent consisting mainly of nitroglycerin
JPS5594316A (en) * 1979-01-11 1980-07-17 Key Pharma Diffusion matrix for medicine release
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
JPS56133381A (en) * 1980-03-25 1981-10-19 Nippon Kayaku Co Ltd Pressure-sensitive adhesive tape or sheet containing nitroglycerin
JPS5714522A (en) * 1980-06-09 1982-01-25 Key Pharma Polymer diffused matrix
CA1163195A (en) * 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
JPS5759806A (en) * 1980-08-11 1982-04-10 Searle & Co Nitroglycerine pad for percutaneous administration
JPS5777617A (en) * 1980-10-20 1982-05-15 Nichiban Co Ltd Plaster for cardiac disease
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
GB2156215B (en) * 1984-03-05 1988-03-02 Nitto Electric Ind Co Percutaneous absorption type adhesive pharmaceutical preparation
WO1986000814A1 (en) * 1984-07-24 1986-02-13 Key Pharmaceuticals, Inc. Adhesive transdermal dosage layer
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
JPH0696529B2 (ja) * 1987-03-31 1994-11-30 積水化学工業株式会社 ニトログリセリン貼付剤およびその製造方法

Also Published As

Publication number Publication date
EP0450986A2 (en) 1991-10-09
JPH03291217A (ja) 1991-12-20
KR910018019A (ko) 1991-11-30
NO177663C (no) 1995-11-01
DE69107493D1 (de) 1995-03-30
DK0450986T3 (da) 1995-05-08
NO911344L (no) 1991-10-07
NO177663B (no) 1995-07-24
IE911136A1 (en) 1991-10-09
US5260064A (en) 1993-11-09
FI911652L (fi) 1991-10-07
KR0163597B1 (ko) 1998-12-01
IE66144B1 (en) 1995-12-13
EP0450986B1 (en) 1995-02-22
JPH07116032B2 (ja) 1995-12-13
CA2039869C (en) 1998-10-27
CA2039869A1 (en) 1991-10-07
EP0450986A3 (en) 1991-12-18
DE69107493T2 (de) 1995-06-14
FI102038B (fi) 1998-10-15
NO911344D0 (no) 1991-04-05
FI911652A0 (fi) 1991-04-05
FI102038B1 (fi) 1998-10-15

Similar Documents

Publication Publication Date Title
ES2068502T3 (es) Un preparado farmaceutico de nitroglicerina, del tipo de administracion percutanea.
ATE96308T1 (de) Dosierform fuer verabreichung in der humanmedizin.
ATE150979T1 (de) Injektionsstift für mehrfachdosierung
DE3680754D1 (de) Poroese biologisch absorbierbare polyester.
ES2121793T3 (es) Composiciones de uso local para la administracion transdermica de derivados profarmacos de morfina.
FI93352C (fi) Menetelmä farmakologisesti aktiivisten aromaattisten estereiden ja tioestereiden valmistamiseksi
PT101061A (pt) Composicoes farmaceuticas contendo anagolos da camptotecina e um composto de coordenacao de platina e seu uso na inibicao do crescimento de celulas tumorais
ES2146589T3 (es) Preparacion medicamentosa para jeringa.
DK0768867T3 (da) Doseringsform til indgivelse af lægemiddel i væskeformig formulering
DK567088D0 (da) Indretning til transdermal laegemiddelindgift
NO166687C (no) Fremgangsmaate for fremstilling av en stabil, vandig, injiserbar opploesning av piroxicam.
MY103746A (en) Improvements in or relating to somatostatins
DE69228952D1 (de) Verwendung von psoralen-verbindungen zur hemmung von auf gefaessplastiken folgende restenosen
ES2032905T3 (es) Sistema terapeutico transcutaneo.
ES2070401T3 (es) Preparacion para la administracion transdermica de farmacos.
DK499088D0 (da) 1-oe(2-pyrimidinyl)-aminoalkylaapiperidinderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende saadanne derivater
SE8703032L (sv) Perkutan administrering av lekemedel
ATE141802T1 (de) Illudin-analoge, verwendet als antitumormittel
JPS6468316A (en) External plaster containing salbutamol
ES2042523T3 (es) Procedimiento para la preparacion de pirido-(2,3-b)(1,4)-benzodiazepin-6-onas.
GR1003550B (el) Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων
SE7907621L (sv) Etomidat-haltiga kompositioner
DE3881484D1 (de) Optisch aktive produkte von 20,21-dinoreburnamenin-derivaten, verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 450986

Country of ref document: ES